Image Source - Unsplash
By, Medical News Tip Friday, September 22, 2023
The NIH plans to test a new HIV vaccine in the U.S. and South Africa, aiming to end the HIV epidemic by 2030.
Image Source - Unsplash
The vaccine, VIR-1388, employs CMV, potentially providing long-lasting protection against HIV and addressing immunity challenges.
Image Source - Unsplash
Clinical trials will occur in 10 locations, and results are expected by late 2024.
Image Source - Unsplash
Developing an HIV vaccine is challenging due to the virus's constant mutations.
Image Source - Unsplash
In March 2022, NIH began mRNA HIV vaccine trials designed to target the virus's mutations.
Image Source - Unsplash
Many see an HIV vaccine as vital. By late 2022, around 39 million, including 1.5 million children, had HIV.
Image Source - Unsplash
1 in 25 adults grapple with high HIV rates, highlighting the urgent need for prevention and treatment efforts.
Image Source - Unsplash
Over four decades, HIV-related illnesses have claimed more than 40 million lives since its emergence.
Image Source - Unsplash
NIH, alongside other organizations, funds research for an HIV cure, supported by the Gates Foundation and Vir Biotechnology.
Image Source - Unsplash